NCT00246246View on ClinicalTrials.gov

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

April 30, 2006

Conditions
Bipolar Disorder
Interventions
DRUG

risperidone

All Listed Sponsors
lead

Janssen-Ortho Inc., Canada

INDUSTRY

NCT00246246 - A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder | Biotech Hunter | Biotech Hunter